Logo Logo Logo Logo Logo
  • Our Science
  • Pipelines & Programs
  • Noregen™
  • About Us
  • News & Insights
  • Contact
  • Our Science
  • Pipelines & Programs
  • Noregen™
  • About Us
  • News & Insights
  • Contact

Retinal Vascular Rescue of Oxygen-Induced Retinopathy in Mice by Norrin

01 Jul Retinal Vascular Rescue of Oxygen-Induced Retinopathy in Mice by Norrin

Posted at 16:31h in News, Publications by Caeregen Therapeutics
Share

Wnt-signaling has been implicated in retinal development. The aim of this study was to investigate the possibility of improving retinal vasculature in an animal model of retinopathy by activating Wnt-signaling.

Read more…

Tags:
Norrin, Retinopathy, Wnt-Signaling


Recent Posts
  • A Tribute to Dr. Michael T. Trese, Co-Founder and Chief Technology Officer of Caeregen Therapeutics
  • Caeregen Therapeutics Announces FDA Rare Pediatric Disease Designation for Noregen™ in the Treatment Of Familial Exudative Vitreoretinopathy (FEVR)  
  • “Update in Understanding and Managing FEVR” published in Retina Today, featuring Dr. Kimberly A. Drenser, MD, PhD
  • Development of Noregen™, A Novel Regenerative Ocular Therapeutic Medicine
  • Caeregen Therapeutics Announces Data Presentation at the Association for Research in Vision and Ophthalmology (ARVO) 2022 Annual Meeting
Categories
  • News
  • Presentation
  • Publications
Tags
American Academy of Ophthalmology (AAO) diabetic retinopathy FDA FEVR Frizzled4 Lrp5 Noregen Norrin Priority Review Voucher Rare Pediatric Disease retinal hypovascularization Retinal Vascular Disease retinal vein occlusion Retinopathy retinopathy of prematurity vascular regrowth VEGF vessel regrowth Wnt-Signaling

Caeregen Therapeutics discovers and develops novel therapies which repair, restore, and protect damaged and diseased tissues by reactivating the pathways and signaling which accompany normal cellular and tissue development. Our revolutionary regenerative medicine restores lost or degraded functioning to diseased tissue and organs.

SITE MAP
  • Our Science
  • Pipelines & Programs
  • Noregen™
  • About Us
  • News & Insights
  • Contact
CONTACT

510 Meadowmont Village Circle
Suite 303, Chapel Hill, NC 27517
Email: [email protected]
Phone: (203) 278-1172

JOIN INTEREST LIST
© 2021 Caeregen Therapeutics | Contact | Privacy Policy | Terms & Conditions